Aminoguanidine ameliorates splanchnic hyposensitivity to glypressin in a haemorrhage-transfused rat model of portal hypertension

Clinical Science

Volumn 95, Issue 5, 1998, Pages 629-636

  Chu, Chi Jen ^a   Lee, Fa Yauh ^a   Wang, Sun Sang ^a   Chang, Full Young ^a   Lin, Han Chieh ^a   Hou, Ming Chih ^a   Wu, Shwu Ling ^a   Tai, Chung Ching ^a   Chan, Che Chang ^a   Lee, Shou Dong ^a  

^a NONE

Author keywords

Aminoguanidine; Glypressin; Haemorrhage; Hyposensitivity; Nitric oxide; Portal hypertension

Indexed keywords

AMINOGUANIDINE; NITRIC OXIDE; TERLIPRESSIN; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; CONTROLLED STUDY; DRUG EFFECT; HEART RATE; HEMORRHAGIC SHOCK; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; RAT; VEIN LIGATION;

EID: 0031739795     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0950629     Document Type: Article

References (38)

1. D'Amico, G., Pagliaro, L. and Bosch, J. (1995) The treatment of portal hypertension: a meta-analytic review. Hepatology 22, 332-354
2. Kravetz, D., Cummings, S. A. and Groszmann, R. J. (1987) Hyposensitivity to vasopressin in a haemorrhage-transfused rat model of portal hypertension. Gastroenterology 93, 170-175
3. Valla, D., Girod, C., Lee, S. S., Braillon, A. and Lebrec, D. (1988) Lack of vasopressin action on splanchnic haemodynamics during bleeding: a study in conscious, portal hypertensive rats. Hepatology 8, 10-15
4. Tsai, Y. T., Lee, F. Y., Lin, H. C. et al. (1991) Hyposensitivity to vasopressin in patients with hepatitis B-related cirrhosis during acute variceal haemorrhage. Hepatology 13, 407-412
5. Valla, D., Geoffroy, P., Girod, C. and Lebrec, D. (1986) Circulatory actions of vasopressin in anesthetized rats with portal hypertension subjected to haemorrhage. J. Hepatol. 2, 328-339
6. Paller, M. S. and Linas, S. L. (1984) Role of angiotensin II, alpha-adrenergic system and arginine vasopressin on arterial pressure in the rat. Am. J. Physiol. 246, H25-H30
7. Haddy, F. T., Scott, J. B. and Molnar, J. I. (1965) Mechanism of volume replacement and vascular constriction following haemorrhage. Am. J. Physiol. 208, 169-181
8. Vorobioff, J., Bredfeldt, J. E. and Groszmann, R. J. (1983) Hyperdynamic circulation in portal hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am. J. Physiol. 244, G52-G57
9. Schrier, R. W. and Caramelo, C. (1988) Haemodynamic and hormonal alternations in hepatic cirrhosis. In The Kidney in Liver Disease (Epstein, M., ed.), pp. 265-285, Williams and Wilkins, Baltimore
10. Lee, F. Y., Albillos, A., Colombato, L. A. and Groszmann, R. J. (1992) The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats. Hepatology 16, 1043-1048
11. Sieber, C. C. and Groszmann, R. J. (1992) In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide inhibition. Am. J. Physiol. 262, G996-G1001
12. Pizcueta, P., Piqué, J. M., Fernandéz, M. et al. (1992) Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 103, 1909-1915
13. ω-nitro-L-arginine administration corrects peripheral vasodilation and systemic capillary hypotension, and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats. Hepatology 17, 84-90
14. Thiemermann, C., Szabó, C., Mitchell, J. A. and Vane, J. R. (1993) Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 90, 267-271
15. ω-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality in awake canines challenged with endotoxin. J. Exp. Med. 176, 1175-1182
16. Nava, E., Palmer, R. M. J. and Moncada, S. (1991) Inhibition of nitric oxide synthesis in septic shock: how much is benefit? Lancet 338, 1555-1557
17. Wright, C. E., Rees, D. D. and Moncada, S. (1992) Protective and pathological roles of nitric oxide in endotoxic shock. Cardiovasc. Res. 26, 48-57
18. Griffiths, M. J. D., Messent, M., MacAllister, R. J. and Evans, T. W. (1993) Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br. J. Pharmacol. 110, 963-968
19. Misko, T. P., Moore, W. M., Kasten, T. P. et al. (1993) Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol. 233, 119-125
20. Chojkier, M. and Groszmann, R. J. (1981) Measurement of the portal-systemic shunting in the rat by using γ-labeled microspheres. Am. J. Physiol. 240, G371-G375
21. Sapirstein, L. A., Sapirstein, E. A. and Bredemer, A. (1960) Effects of haemorrhage on the cardiac output and its distribution in the rat. Circ. Res. 8, 135-148
22. Neutze, J. M., Wyler, F. and Rudolph, A. M. (1968) Changes in distribution of cardiac output after hemorrhage in rabbits. Am. J. Physiol. 215, 857-864
23. Kaihara, S., Rutherford, R. B., Schwentker, E. P. and Wagner, Jr, H. N. (1969) Distribution of cardiac output in experimental hemorrhagic shock in dogs. J. Appl. Physiol. 27, 218-222
24. Vatner, S. F. (1974) Effects of haemorrhage on regional blood flow distribution in dogs and primates. J. Clin. Invest. 54, 225-235
25. Laycock, J. F., Penn, W., Shirley, D. G. and Walter, S. J. (1979) The role of vasopressin in blood pressure regulation immediately following acute hemorrhage in the rat. J. Physiol. 296, 267-275
26. Wang, B. C., Sundet, W. D., Hakumaki, M. O. K. and Goetz, K. L. (1983) Vasopressin and renin responses to haemorrhage in conscious, cardiac denervated dogs. Am. J. Physiol. 245, H399-H405
27. Feuerstein, G., Molineaux, C. J., Rosenberger, J. G., Zerbe, R. L., Cox, B. M. and Faden, A. I. (1985) Haemorrhagic shock and the central vasopressin and opioid peptide system of rats. Am. J. Physiol. 249, E244-E250
28. Chien, S. (1967) Role of the sympathetic nervous system in haemorrhage. Physiol. Rev. 47, 214-288
29. Lopez-Talavera, J. C. and Grozmann, R. J. (1994) Treatment with aminoguanidine, a specific inhibitor of the inducible nitric oxide synthase, ameliorates the hyperdynamic syndrome in portal hypertensive rats. Hepatology 20, 143A
30. Lee, F. Y., Wang, S. S., Tsai, Y. T. et al. (1997) Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats. J. Hepatol. 26, 687-693
31. Gräfe, M., Bossaller, C., Graf, K. et al. (1993) Effects of angiotensin-converting-enzyme inhibition on bradykinin metabolism by vascular endothelial cells. Am. J. Physiol. 264, H1493-H1497
32. Tesfamariam, B. and Cohen, R. A. (1988) Inhibition of adrenergic vasoconstriction by endothelial cell shear stress. Circ. Res. 63, 720-725
33. Rubanyi, G. M., Freay, A. D., Kauser, K., Johns, A. and Harder, D. R. (1990) Mechanoreception by the endothelium: mediators and mechanisms of pressure- and flow-induced vascular responses. Blood vessels 27, 246-257
34. Moncada, S., Palmer, R. M. J. and Higgs, E. A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142
35. Miller, V. M. and Vanhoutte, P. (1989) Endothelium-dependent responses and their potential relevance to the distribution of blood flow during haemorrhagic shock. Resuscitation 18, 165-171
36. Avala, A., Perrrin, M. M., Meldrum, D. R., Ertel, W. and Chaudry, I. H. (1990) Differential effects of hemorrhage on Kupffer cells: decreased antigen presentation despite increased inflammatory cytokine (IL-1, IL-6 and TNF) release. Cytokine 2, 170-174
37. Ayala, A., Wang, P., Ba, Z. F., Perrin, M. M., Ertel, W. and Chaudry, I. H. (1991) Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage. Am. J. Physiol. 260, R167-R171
38. Niederberger, M., Gines, P., Martin, P. Y. et al. (1996) Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Hepatology 24, 947-951